Public-private partnership in cord blood banking

Fisk, Nicholas M. and Atun, Rifat (2008) Public-private partnership in cord blood banking. BMJ: British Medical Journal, 336 7645: 642-644. doi:10.1136/bmj.39489.454699.AD

Author Fisk, Nicholas M.
Atun, Rifat
Title Public-private partnership in cord blood banking
Journal name BMJ: British Medical Journal
ISSN 0959-535X
Publication date 2008-03-22
Year available 2008
Sub-type Article (original research)
DOI 10.1136/bmj.39489.454699.AD
Open Access Status DOI
Volume 336
Issue 7645
Start page 642
End page 644
Total pages 3
Editor Richard Smith
Place of publication London, U.K.
Publisher British Medical Association
Language eng
Subject C1
111402 Obstetrics and Gynaecology
1114 Paediatrics and Reproductive Medicine
Formatted abstract
Cord blood is usually discarded at birth but is rich in haemopoietic stem cells, which are increasingly used as an alternative to bone marrow for transplantation. Umbilical blood may also contain mesenchymal stem cells, which in future might be used to repair damaged tissues in a range of diseases such as strokes, heart attacks, renal failure, and diabetes.

Many countries established altruistic public banks of cord blood in response to the increasing need for haemopoietic stem cells for patients with leukaemia and genetic conditions. The limited coverage of these banks, together with the future potential for stem cell cures, led to the introduction of private autologous banking of both haemopoietic and mesenchymal stem cells from cord blood. However, many health professionals oppose private banking because of its speculative and commercial nature. Consumers face an array of providers with conflicting information on the usefulness of banked cord blood. We analyse the growing cord blood banking industry in the UK and the potential impact of Virgin Health Bank’s novel model that provides blood for both personal use and public banks.

Summary points:
-Public banks of cord blood have proved valuable for allogeneic transplantation
-Cord blood banked privately as biological insurance is unlikely to be used
-Virgin Health Bank has adopted a new model, storing 20% for private use and 80% for public use
-The bank will also support stem cell research
-Logistics of collection remain a barrier to professional and government support
Keyword Cord blood
Haemopoietic stem cells
Mesenchymal stem cells,
Public banks of cord blood
Virgin Health Bank
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Excellence in Research Australia (ERA) - Collection
UQ Centre for Clinical Research Publications
ERA 2012 Admin Only
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 20 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 27 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 07 Apr 2009, 23:45:16 EST by Carmen Buttery on behalf of Faculty Of Health Sciences